SAN DIEGO, May 7, 2013 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. ("Apricus Bio" or the "Company") (APRI) (www.apricusbio.com) announced today that John P. Mulhall, MD, Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan-Kettering Cancer Center, will present results from an analysis of existing Phase 3 data for Vitaros(R), the Company's lead product candidate for the treatment of erectile dysfunction (ED), at the American Urological Association Annual Meeting which is taking place May 4-8, 2013 in San Diego, CA.
The abstract titled, "Vitaros(R) Efficacy and Safety in Viagra(R) Non-Responders with Longer Term Use," will be presented as a moderated poster (#1519) during a session titled "Sexual Function/Dysfunction/Andrology: Medical and Non-Surgical Therapy," taking place Tuesday, May 7, 2013 from 8-10 a.m. local time. Dr. Mulhall will give a short oral presentation, which will then be followed by a question and answer period.
This analysis evaluated the safety and efficacy of Vitaros(R) after 12 weeks, and longer term use, in men previously unresponsive to phosphodiesterase type 5 (PDE-5) inhibitors, such as Viagra(R) (n=325). Results showed that 200mcg and 300mcg doses of Vitaros(R) improved erections in this population and adverse events (AE) were mild to moderate, similar to those seen in the control group, and decreased with repeated exposure.
"PDE-5 inhibitors, while effective, address only a portion of the ED patient population. In the current treatment landscape, this leaves a large population of unresponsive or contraindicated patients with few or no alternatives," said Dr. John Mulhall, lead author and Director of the Male Sexual and Reproductive Medicine Program at Memorial Sloan-Kettering Cancer Center. "Vitaros(R) utilizes a novel mechanism of action that has demonstrated successful ED therapy without the side effects associated with current products, making it an effective and practical option for these patients."
Dr. Mulhall is also an Associate Editor for the Journal of Sexual Medicine and past President of the Sexual Medicine Society of North America.
About Vitaros(R)
Vitaros(R), Apricus Bio's lead product candidate for the treatment of ED, is a topically-applied cream formulation of alprostadil, a vasodilator, which directly increases blood flow to the penis, causing an erection. Vitaros is approved in Canada and Apricus Bio has filed for regulatory approval in Europe. Alprostadil is a widely accepted alternative to the PDE5 inhibitors for difficult to treat patients, and Vitaros(R) is relatively safe and effective, and offers greater market opportunity due to its patient-friendly form versus both other alprostadil dosage forms and also relative to oral ED products. With a market affecting nearly 150 million men worldwide and representing approximately $2.6 billion in revenue -- excluding the U.S. -- Vitaros(R) represents a major market opportunity, particularly as a distinct product that addresses a significant underserved population.
About Apricus Biosciences, Inc.
Apricus Biosciences, Inc. (APRI) is a pharmaceutical company that develops and markets innovative treatments that help large patient populations across numerous, large-market therapeutic classes including male and female sexual health. The Company has one approved product, Vitaros(R), for the treatment of erectile dysfunction, which will be marketed in Canada by Abbott Laboratories, and Femprox(R), a product candidate, for the treatment of female sexual arousal disorder, which successfully completed one approximately 400-patient Phase III study in China.
For further information on Apricus Bio, visit http://www.apricusbio.com. You can also receive information at http://twitter.com/apricusbio.
Original post:
- The truth about guys and sex: They fake it, too - April 29th, 2013 [April 29th, 2013]
- Rock-It Man male sexual performance drug recalled - April 29th, 2013 [April 29th, 2013]
- Judge approves class-action lawsuit over erectile dysfunction link to prostate, baldness drugs - April 29th, 2013 [April 29th, 2013]
- Apricus, Innovus tackle bedroom disorders - April 29th, 2013 [April 29th, 2013]
- Ask Dr. K: Precautions for male bicyclists - April 29th, 2013 [April 29th, 2013]
- Advanced Male Medical Center Announces Hiring of Erick Salazar - April 29th, 2013 [April 29th, 2013]
- Faking the big O - April 29th, 2013 [April 29th, 2013]
- Priapus Shot - Video - April 29th, 2013 [April 29th, 2013]
- Trimel Submits New Drug Application for CompleoTRT(TM) to FDA - April 30th, 2013 [April 30th, 2013]
- 4 Bio Stocks to Buy Today - May 1st, 2013 [May 1st, 2013]
- Class-Action Lawsuit on Propecia Erectile Dysfunction Approved: Now, AttorneyOne Can Provide Advice - May 3rd, 2013 [May 3rd, 2013]
- Trimel to Report First Quarter 2013 Results and Host Investor Call - May 3rd, 2013 [May 3rd, 2013]
- Acupuncture Presentation Part 2 - Video - May 6th, 2013 [May 6th, 2013]
- Sixty-One Per Cent of Women Say their Sex Lives are Suffering Due to a Condition of Menopause - May 7th, 2013 [May 7th, 2013]
- Dietary Supplement Lightning Rod Capsules Recall - May 8th, 2013 [May 8th, 2013]
- Apricus Biosciences Announces First Quarter 2013 Financial Results Conference Call - May 8th, 2013 [May 8th, 2013]
- BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Special Meetings of Stockholders to Consider Proposed Merger - May 9th, 2013 [May 9th, 2013]
- Why Wait? Enlast Personal Male Lubricant. Stop Premature Ejaculation In Its Tracks With Enlast.flv - Video - May 9th, 2013 [May 9th, 2013]
- Searching For Male Fountain of Youth? Go Exercise - May 11th, 2013 [May 11th, 2013]
- BioSante Pharmaceuticals, Inc. Reports First Quarter Financial Results - May 11th, 2013 [May 11th, 2013]
- Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- DGAP-News: Apricus Biosciences Provides First Quarter 2013 Corporate Update - May 11th, 2013 [May 11th, 2013]
- Sex and the elderly male - May 12th, 2013 [May 12th, 2013]
- Couple sues state over toddler's sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- Columbia couple sues state over toddler’s sexual-reassignment surgery - May 15th, 2013 [May 15th, 2013]
- If Sexual Dysfunction Were a Virus, "It'd Be Pandemic": Expert - May 16th, 2013 [May 16th, 2013]
- Couple files groundbreaking lawsuit over child’s sexual-reassignment surgery - May 16th, 2013 [May 16th, 2013]
- The Dangers Lurking in Male Sexual Supplements - May 17th, 2013 [May 17th, 2013]
- West Jordan man pleads guilty to falsely advertising, selling Viagra-like drug - May 17th, 2013 [May 17th, 2013]
- Manning up to the church - May 20th, 2013 [May 20th, 2013]
- Boy who manned up to the church - May 20th, 2013 [May 20th, 2013]
- The low-down on erectile problems - May 21st, 2013 [May 21st, 2013]
- Study: Genital Warts May Lead to Sexual Dysfunction; polyDNA Recommends Gene-Eden-VIR Against the Genital Warts Virus - May 22nd, 2013 [May 22nd, 2013]
- Quit smoking for a better sex life - study - May 22nd, 2013 [May 22nd, 2013]
- If It Doesn’t Make Us Nymphos, Female Viagra Will Save Monogamy - May 23rd, 2013 [May 23rd, 2013]
- Erectile dysfunction drugs sold as herbal medicine - May 24th, 2013 [May 24th, 2013]
- Heart failure ups risk of male menopause 4 fold - May 25th, 2013 [May 25th, 2013]
- Heart failure accelerates male 'menopause' - May 25th, 2013 [May 25th, 2013]
- New Asia-Pacific Sexual Satisfaction Study Pulls Back the Covers on Relationship Tension Facing Couples - May 28th, 2013 [May 28th, 2013]
- Heart Disease Accelerates Male Menopause - May 29th, 2013 [May 29th, 2013]
- Igniting woman's sexual desire is more than popping pill - May 30th, 2013 [May 30th, 2013]
- Warning: 'Natural' sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Dangers of sex supplements - May 31st, 2013 [May 31st, 2013]
- Warning: Men's natural sex supplements may not be - May 31st, 2013 [May 31st, 2013]
- Sex is doctor's life's work - June 1st, 2013 [June 1st, 2013]
- Sex is life's work for doctor - June 3rd, 2013 [June 3rd, 2013]
- Sexual stress common in men - June 6th, 2013 [June 6th, 2013]
- Sexual performance anxiety - June 6th, 2013 [June 6th, 2013]
- Affirm XL, Inc. Re-launches U.S. Made Sexual Enhancement Dietary Supplement - June 6th, 2013 [June 6th, 2013]
- Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- DGAP-News: Apricus Biosciences Receives European Approval for Vitaros(R) for the Treatment of Erectile Dysfunction - June 11th, 2013 [June 11th, 2013]
- BPA linked to obesity risk in puberty-age girls - June 13th, 2013 [June 13th, 2013]
- Baldness drug curbs interest in alcohol, study says- Fla. mom dies after butt enhancing injections - June 14th, 2013 [June 14th, 2013]
- Anti-baldness drug can cause men to lose interest in alcohol - June 14th, 2013 [June 14th, 2013]